Multiple Sclerosis (MS) Drugs Market Report – Research, Industry Analysis Reports and Market Demands

Multiple Sclerosis (MS) Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)

Request for Sample of this report

Buy now

Table of Content

1 Industrial Chain Overview

1.1 Multiple Sclerosis (MS) Drugs Industry
- 1.1.1 Overview

Figure Multiple Sclerosis (MS) Drugs Picture List

1.1.2 Characteristics of Multiple Sclerosis (MS) Drugs

1.2 Upstream

1.2.1 Major Materials
1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Copaxone (Glatiramer Acetate, Copolymer 1)
1.3.2 Novantrone (Mitoxantrone)
1.3.3 Gilenya (Fingolimod, Fty720)
1.3.4 Aubagio (Teriflunomide)
1.3.5 Tecfidera (Dimethyl Fumarate)
1.3.6 Firategrast (Sb683699, T-0047)
1.3.7 Siponimod (Baf312)
1.3.8 Others

1.4 End-Use List

1.4.1 Demand in RRMS
1.4.2 Demand in SPMS
1.4.3 Demand in PPMS
1.4.4 Demand in PRMS

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2017-2027

Figure Global Market Size and Forecast with Growth Rate, 2017-2027

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027

Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027

Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027

Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption
- 2.1.1 Global Production

Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume

Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD

2.1.2 Global Consumption

Figure Global Market Volume and Growth Rate, 2017-2021, in Volume

Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD

2.2 Geographic Production & Consumption
- 2.2.1 Production
  - 2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
- 2.2.1.2 North America

Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume

Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.3 South America

Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume

Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.4 Europe

Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.5 Middle East & Africa

Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.2 Consumption
- 2.2.2.1 Asia-Pacific

Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume

Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.2 North America

Figure North America Market Volume and Growth Rate, 2017-2021, in Volume

Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD

Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.3 South America

Figure South America Market Volume and Growth Rate, 2017-2021, in Volume

Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD

Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.4 Europe

Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume

Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.5 Middle East & Africa

Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume

Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2021

3.2 Manufacturers List
- 3.2.1 Bayer AG Overview

Table Bayer AG Overview List

3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Bayer AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning

3.2.2 Bayhill Therapeutics Overview

Table Bayhill Therapeutics Overview List

3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Bayhill Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning

3.2.3 Biogen Idec Overview

Table Biogen Idec Overview List

3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Biogen Idec (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning

3.2.4 Cinnagen Overview

Table Cinnagen Overview List

3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Cinnagen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning

3.2.5 Daiichi Sankyo Overview

Table Daiichi Sankyo Overview List

3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Daiichi Sankyo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning

3.2.6 Eli Lilly Overview

Table Eli Lilly Overview List

3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning

3.2.7 Fast Forward Llc Overview

Table Fast Forward Llc Overview List

3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Fast Forward Llc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning

3.2.8 Antisense Therapeutics Overview

Table Antisense Therapeutics Overview List

3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Antisense Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning

3.2.9 Apitope Overview

Table Apitope Overview List

3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Apitope (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning

3.2.10 Five Prime Therapeutics Overview

Table Five Prime Therapeutics Overview List

3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Five Prime Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning

3.2.11 Genmab Overview

Table Genmab Overview List

3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Genmab (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning

3.2.12 Artielle Immunotherapeutics Overview

Table Artielle Immunotherapeutics Overview List

3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Artielle Immunotherapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning

3.2.13 Genzyme Overview

Table Genzyme Overview List

3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Genzyme (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning

3.2.14 Glaxosmithkline Overview

Table Glaxosmithkline Overview List

3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Glaxosmithkline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning

3.2.15 Gw Pharmaceuticals Overview

Table Gw Pharmaceuticals Overview List

3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Gw Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning

3.2.16 Innate Immunotherapeutics Overview

Table Innate Immunotherapeutics Overview List

3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Multiple Sclerosis (MS) Drugs Business Operation of Innate Immunotherapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

Figure Global Market Size and Growth Rate, 2017-2021, in Volume

Figure Global Market Size and Growth Rate, 2017-2021, in Million USD

Figure Global Competition Sketch Overview

4.2 Company Market Share
- 4.2.1 Global Production by Major Manufacturers

Table Global Production Volume List by Manufacturers, 2017-2021, in Volume

Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume

Figure Global Production Volume Share by Manufacturers in 2021, in Volume

Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD

Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD

Figure Global Production Amount Share by Manufacturers in 2021, in Million USD

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition
4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume

5.2 Segment Subdivision by Product Type
- 5.2.1 Market in Copaxone (Glatiramer Acetate, Copolymer 1)
  - 5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Copaxone (Glatiramer Acetate, Copolymer 1), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Copaxone (Glatiramer Acetate, Copolymer 1), 2017-2021, in Volume
- 5.2.1.2 Situation & Development
5.2.2 Market in Novantrone (Mitoxantrone)
- 5.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Novantrone (Mitoxantrone), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Novantrone (Mitoxantrone), 2017-2021, in Volume

5.2.2.2 Situation & Development

5.2.3 Market in Gilenya (Fingolimod, Fty720)

5.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Gilenya (Fingolimod, Fty720), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Gilenya (Fingolimod, Fty720), 2017-2021, in Volume

5.2.3.2 Situation & Development

5.2.4 Market in Aubagio (Teriflunomide)

5.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in Aubagio (Teriflunomide), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Aubagio (Teriflunomide), 2017-2021, in Volume

5.2.4.2 Situation & Development

5.2.5 Market in Tecfidera (Dimethyl Fumarate)

5.2.5.1 Market Size

Figure Global Market Amount and Growth Rate in Tecfidera (Dimethyl Fumarate), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Tecfidera (Dimethyl Fumarate), 2017-2021, in Volume

5.2.5.2 Situation & Development

5.2.6 Market in Firategrast (Sb683699, T-0047)

5.2.6.1 Market Size

Figure Global Market Amount and Growth Rate in Firategrast (Sb683699, T-0047), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Firategrast (Sb683699, T-0047), 2017-2021, in Volume

5.2.6.2 Situation & Development

5.2.7 Market in Siponimod (Baf312)

5.2.7.1 Market Size

Figure Global Market Amount and Growth Rate in Siponimod (Baf312), 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Siponimod (Baf312), 2017-2021, in Volume

5.2.7.2 Situation & Development

5.2.8 Market in Others

5.2.8.1 Market Size

Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2017-2021, in Volume

5.2.8.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume

6.2 Segment Subdivision
- 6.2.1 Market in RRMS
  - 6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in RRMS, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in RRMS, 2017-2021, in Volume
- 6.2.1.2 Situation & Development
6.2.2 Market in SPMS
- 6.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in SPMS, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in SPMS, 2017-2021, in Volume

6.2.2.2 Situation & Development

6.2.3 Market in PPMS

6.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in PPMS, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in PPMS, 2017-2021, in Volume

6.2.3.2 Situation & Development

6.2.4 Market in PRMS

6.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in PRMS, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in PRMS, 2017-2021, in Volume

6.2.4.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

Table Global Market Forecast by Region Segment 2022-2027, in Million USD

Table Global Market Forecast by Region Segment 2022-2027, in Volume

7.2 Consumption Forecast
- 7.2.1 Product Type Forecast

Table Global Market Amount by Product Type Segment 2022-2027, in Million USD

Table Global Market Volume by Product Type Segment 2022-2027, in Volume

7.2.2 End-Use Forecast

Table Global Market Amount by End-Use Segment 2022-2027, in Million USD

Table Global Market Volume by End-Use Segment 2022-2027, in Volume

7.3 Investment Trend
7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost
- 8.1.1 Price
- 8.1.2 Cost

Figure Cost Component Ratio

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Multiple Sclerosis (MS) Drugs Industry
- 9.3.1 Impact on Industry Upstream
- 9.3.2 Impact on Industry Downstream
- 9.3.3 Impact on Industry Channels
- 9.3.4 Impact on Industry Competition
- 9.3.5 Impact on Industry Employment

10 Research Conclusion

List of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027

Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027

Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027

Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume

Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2021

Table Bayer AG Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Bayer AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bayhill Therapeutics Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Bayhill Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Biogen Idec Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Biogen Idec (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Cinnagen Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Cinnagen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Daiichi Sankyo Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Daiichi Sankyo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Fast Forward Llc Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Fast Forward Llc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Antisense Therapeutics Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Antisense Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Apitope Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Apitope (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Five Prime Therapeutics Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Five Prime Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Genmab Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Genmab (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Artielle Immunotherapeutics Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Artielle Immunotherapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Genzyme Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Genzyme (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Glaxosmithkline Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Glaxosmithkline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Gw Pharmaceuticals Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Gw Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Innate Immunotherapeutics Overview List

Table Multiple Sclerosis (MS) Drugs Business Operation of Innate Immunotherapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2017-2021, in Volume

Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume

Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD

Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume

Table Global Market Forecast by Region Segment 2022-2027, in Million USD

Table Global Market Forecast by Region Segment 2022-2027, in Volume

Table Global Market Amount by Product Type Segment 2022-2027, in Million USD

Table Global Market Volume by Product Type Segment 2022-2027, in Volume

Table Global Market Amount by End-Use Segment 2022-2027, in Million USD

Table Global Market Volume by End-Use Segment 2022-2027, in Volume

List of Figure

Figure Multiple Sclerosis (MS) Drugs Picture List

Figure Global Market Size and Forecast with Growth Rate, 2017-2027

Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Global Market Volume and Growth Rate, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD

Figure North America Market Volume and Growth Rate, 2017-2021, in Volume

Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD

Figure South America Market Volume and Growth Rate, 2017-2021, in Volume

Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume

Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume

Figure Middle E

Description

According to 99Strategy, the Global Multiple Sclerosis (MS) Drugs Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Multiple Sclerosis (MS) Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Bayer AG
Bayhill Therapeutics
Biogen Idec
Cinnagen
Daiichi Sankyo
Eli Lilly
Fast Forward Llc
Antisense Therapeutics
Apitope
Five Prime Therapeutics
Genmab
Artielle Immunotherapeutics
Genzyme
Glaxosmithkline
Gw Pharmaceuticals
Innate Immunotherapeutics
Key Product Type
Copaxone (Glatiramer Acetate, Copolymer 1)
Novantrone (Mitoxantrone)
Gilenya (Fingolimod, Fty720)
Aubagio (Teriflunomide)
Tecfidera (Dimethyl Fumarate)
Firategrast (Sb683699, T-0047)
Siponimod (Baf312)
Others
Market by Application
RRMS
SPMS
PPMS
PRMS
Main Aspects covered in the Report
Overview of the Multiple Sclerosis (MS) Drugs market including production, consumption, status & forecast and market growth
2017-2021 historical data and 2022-2027 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development

Buy now